1. Home
  2. POAI vs SINT Comparison

POAI vs SINT Comparison

Compare POAI & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • SINT
  • Stock Information
  • Founded
  • POAI 2002
  • SINT 1996
  • Country
  • POAI United States
  • SINT United States
  • Employees
  • POAI N/A
  • SINT N/A
  • Industry
  • POAI Industrial Specialties
  • SINT Medical/Dental Instruments
  • Sector
  • POAI Health Care
  • SINT Health Care
  • Exchange
  • POAI Nasdaq
  • SINT Nasdaq
  • Market Cap
  • POAI 7.8M
  • SINT 7.9M
  • IPO Year
  • POAI N/A
  • SINT 2014
  • Fundamental
  • Price
  • POAI $0.85
  • SINT $3.07
  • Analyst Decision
  • POAI Hold
  • SINT Strong Buy
  • Analyst Count
  • POAI 1
  • SINT 1
  • Target Price
  • POAI N/A
  • SINT $28.00
  • AVG Volume (30 Days)
  • POAI 168.6K
  • SINT 64.8K
  • Earning Date
  • POAI 08-19-2025
  • SINT 08-19-2025
  • Dividend Yield
  • POAI N/A
  • SINT N/A
  • EPS Growth
  • POAI N/A
  • SINT N/A
  • EPS
  • POAI N/A
  • SINT N/A
  • Revenue
  • POAI $1,729,269.00
  • SINT $2,569,000.00
  • Revenue This Year
  • POAI $486.27
  • SINT N/A
  • Revenue Next Year
  • POAI $65.50
  • SINT $87.50
  • P/E Ratio
  • POAI N/A
  • SINT N/A
  • Revenue Growth
  • POAI 24.17
  • SINT N/A
  • 52 Week Low
  • POAI $0.55
  • SINT $1.71
  • 52 Week High
  • POAI $3.06
  • SINT $8.60
  • Technical
  • Relative Strength Index (RSI)
  • POAI 47.32
  • SINT 52.87
  • Support Level
  • POAI $0.71
  • SINT $2.61
  • Resistance Level
  • POAI $0.82
  • SINT $3.03
  • Average True Range (ATR)
  • POAI 0.05
  • SINT 0.16
  • MACD
  • POAI 0.00
  • SINT 0.05
  • Stochastic Oscillator
  • POAI 63.73
  • SINT 80.56

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

Share on Social Networks: